跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,860 条关于
“Leber hereditary optic neuropathy”
全部
6,860
临床试验
5,781
药物
82
机构
20
资讯
977
去年
GenSight Biologics Successfully Transfers LUMEVOQ Manufacturing to Catalent for LHON Gene Therapy
去年
LUMEVOQ Gene Therapy Shows Sustained Vision Improvement in LHON Patients After 5 Years
去年
GenSight's Gene Therapy Shows Better Outcomes When Administered During Dynamic Phase of LHON Disease
去年
GenSight Biologics Secures French Regulatory Pathway for LUMEVOQ Gene Therapy in Rare Blindness Disease
8个月前
GenSight Biologics Secures €2.9 Million in Latest Fundraising Round for Gene Therapy Development
10天前
GenSight Biologics Advances GS010/LUMEVOQ Manufacturing Transfer and Early Access Programs
10个月前
GenSight Biologics Secures FDA Authorization for Expanded Access Treatment of Rare Blinding Disease
去年
Lenadogene Nolparvovec Shows Sustained Vision Improvement in LHON Patients After 5 Years
9个月前
GenSight Biologics Secures French Regulatory Approvals for GS010/LUMEVOQ Gene Therapy in Rare Blindness Disease
去年
Strategic Partnerships Transform Gene Therapy Manufacturing for Rare Diseases as Market Reaches $11.4 Billion
第 1 页，共 98 页
上一页
下一页
